Viewing Study NCT04223635


Ignite Creation Date: 2025-12-24 @ 10:21 PM
Ignite Modification Date: 2026-02-04 @ 7:37 AM
Study NCT ID: NCT04223635
Status: COMPLETED
Last Update Posted: 2021-06-22
First Post: 2020-01-06
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Study of Pexidartinib in Participants With Moderate Hepatic Impairment Compared With Healthy Participants
Sponsor: Daiichi Sankyo
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Moderate Hepatic Impairment View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Moderate hepatic impaired View
None Healthy subjects View
None Pexidartinib View
None Clinical pharmacology study View
None Tenosynovial giant cell tumor (TGCT) View